[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$mltxs Graphic](https://lunarcrush.com/gi/w:26/t:$mltxs.png) $mltxs

Crypto markets are experiencing volatility. Investors are reacting to the latest project developments.

### About $mltxs
A cryptocurrency project.  

### Engagements: X [#](/topic/$mltxs/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$mltxs/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$mltxs/time-series/interactions.tsv)  
**Current Value**: X  
**Daily Average**: XX  
**1 Week**: XX -XXX%  
**1-Year High**: XX on 2025-04-27  
**1-Year Low**: X on 2025-06-11  

| Social Network | X |
| -------------- | - |
| Engagements    | X |
  

  
  
### Mentions: X [#](/topic/$mltxs/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$mltxs/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$mltxs/time-series/posts_active.tsv)  
**Current Value**: X  
**Daily Average**: X  
**1-Year High**: X on 2025-10-15  
**1-Year Low**: X on 2025-04-27  

| Social Network | X |
| -------------- | - |
| Mentions       | X |
  

  
  
### Creators: X [#](/topic/$mltxs/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$mltxs/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$mltxs/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $mltxs in the last XX hours which is no change from in the previous XX hours
**Daily Average**: X  
**1-Year High**: X on 2025-10-15  
**1-Year Low**: X on 2025-04-27  

**Top assets mentioned**
In the posts about $mltxs in the last XX hours

[MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)](/topic/$mltx)
[Core Scientific, Inc. Common Stock (CORZ)](/topic/core-scientific)
[United Community Banks, Inc. (UCB)](/topic/$ucb)
[Sanofi (SNY)](/topic/sanofi)
[Synthetify (SNY)](/topic/$sny)

**Top topics mentioned**
In the posts about $mltxs in the last XX hours

[$mltx](/topic/$mltx), [core scientific](/topic/core-scientific), [stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries), [stocks bitcoin miners](/topic/stocks-bitcoin-miners), [$ucb](/topic/$ucb), [longterm](/topic/longterm), [$snys](/topic/$snys), [sanofi](/topic/sanofi), [stocks healthcare](/topic/stocks-healthcare), [$sny](/topic/$sny)

### Top Social Posts [#](/topic/$mltxs/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$UCB (Buy)-Bimzelx's Strong Launch Trajectory Should Continue LT In Massive HS Markethave high conviction in Bimzelx's long-term potential which is solidified by $MLTX's sonelokimab HS results. Bimzelx's impressive real-world efficacy has exceeded all expectations and UCB will be incumbent in a large&growing HS market. reiterate our 6B+ Bimzelx peak sales estimate driven by 3B+ opportunity in HS alone. UCB is a clear Buy for the durable earnings growth"  
[X Link](https://x.com/semodough/status/1972681465314820386) [@semodough](/creator/x/semodough) 2025-09-29T15:14Z 41.5K followers, 3191 engagements


"$mltx from Grok Feuerstein s misses tend to come on stock price predictions or M&A speculation (20-30% wrong) not core scientific critiques like $MLTXs VELA setup. For $MLTX specifically his bear case hinges on sonelokimab underperforming vs. Bimzelx due to trial design and benchmark issuesclassic Feuerstein territory where hes rarely off (10% miss rate). But if VELAs Phase X data exceeds expectations (e.g. HiSCR75 significantly above Bimzelxs 33-36%) he could be in that slim XX% wrong bucket. Keep an eye on his X posts (@adamfeuerstein) for real-time updates post-readout"  
[X Link](https://x.com/Biotekster/status/1972325464183328852) [@Biotekster](/creator/x/Biotekster) 2025-09-28T15:40Z XXX followers, XXX engagements


"$SNY's anti-TNFalpha-OX40 dual-targeting nanobody rocks in hidradenitis supp with unprecedented p2 HiSCR75 delta of XX% (cf $MLTX's dual targeting-nanobody 29%)"  
[X Link](https://x.com/RNAiAnalyst/status/1968219253297066113) [@RNAiAnalyst](/creator/x/RNAiAnalyst) 2025-09-17T07:43Z 20.5K followers, 11.2K engagements